MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-05-0021794
Nasa Pharamacutical Private Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹1.28 Cr
▼ 8% YoY
Net profit · FY 2023
₹1.8 Lakh
Net margin 1.4%
EBITDA · FY 2023
₹6.99 Lakh
EBITDA margin 5.5%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹10 Lakh
Secured borrowings
Company age
12 yrs
Est. 2014
Directors on board
3
As per MCA filings
About Nasa Pharamacutical Private Limited
Data last updated:
Nasa Pharamacutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 28 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33110DL2014PTC264095. Its GSTIN is 05AAECN5888Q1ZK (Uttarakhand).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nagendra Bahadur Singh and Abhay Pratap Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at S – 505 School Block Shakarpur, New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.28 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹1.8 Lakh (net margin 1.4%) and EBITDA of ₹6.99 Lakh (EBITDA margin 5.5%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 12% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
Nasa Pharamacutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0021794). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nasapharmaceutical.in.
Company details
CIN U33110DL2014PTC264095
Registration Number 264095
Incorporation Date 28 January 2014
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-05-0021794
Recognitions & Rankings of Nasa Pharamacutical
Contact details
Nasa Pharamacutical Private Limited's registered office is in New Delhi, Delhi. Its website is nasapharmaceutical.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressS – 505 School Block Shakarpur, New Delhi, Delhi, India – 110092
- IndustryPharma, API Manufacturers
To see the full contact details of Nasa Pharamacutical Private Limited, buy the company report.
Comprehensive company report
Nasa Pharamacutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nasa Pharamacutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Nasa Pharamacutical Private Limited, buy the company report.
Financials of Nasa Pharamacutical Private Limited
FY 2023 filings availableNasa Pharamacutical Private Limited reported revenue of ₹1.28 Cr (down 8% YoY) for FY 2023.
Revenue · FY 2023
₹1.28 Cr ▼ 8%
Net profit · FY 2023
₹1.8 Lakh margin 1.4%
EBITDA · FY 2023
₹6.99 Lakh margin 5.5%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
3 years · compounded
▼ 14%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 1%
5 years · compounded
▲ 6%
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 8% fall in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹1.28 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.99 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.8 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.5% | ||||
| Net Profit Margin | 1.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nasa Pharamacutical Private Limited, buy the company report.
Board of directors of Nasa Pharamacutical Private Limited
Nasa Pharamacutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nagendra Bahadur Singh | Director | 28 Jan 2014 | 12 Years 8 Months | Current |
| Abhay Pratap Singh | Director | 28 Jan 2014 | 12 Years 8 Months | Current |
| Shweta Singh | Director | 03 May 2025 | 1 Years 5 Months | Current |
Peer comparison
Nasa Pharamacutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mace Pharma Private Limited | ₹1.29 Cr (FY 2022) | 28.0% | Panchkula, Haryana, India | |||
| Americ N Astos Medicament Private Limited | ₹1.29 Cr (FY 2020) | -22.0% | New Delhi, Delhi, India | |||
| Aptic Pharmaceuticals Private Limited | ₹1.28 Cr (FY 2025) | -2.0% | Thrissur, Kerala, India | |||
| Fountil Life Sciences Private Limited | ₹1.28 Cr (FY 2021) | -76.0% | Mumbai, Maharashtra, India | |||
| Nasa Pharamacutical Private Limitedthis company | ₹1.28 Cr (FY 2023) | ₹1.8 Lakh | 1.4% | -8.0% | New Delhi, Delhi, India | |
| Lyrid Health Care (Bangalore) Private Limited | ₹1.28 Cr (FY 2025) | 11.0% | Bangalore, Karnataka, India |
To see the full peer comparison of Nasa Pharamacutical Private Limited, buy the company report.
Auditor
Nasa Pharamacutical Private Limited is audited by A A R & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A A R & CO. | FY 2023 | 513479C |
Shareholding
The shareholding of Nasa Pharamacutical Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nasa Pharamacutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 Jul 2023 | 100773179 | State Bank of India | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nasa Pharamacutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nasa Pharamacutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nasa Pharamacutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAECN5888Q1ZK | Uttarakhand | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nasa Pharamacutical Private Limited, buy the company report.
Recent activity
Nasa Pharamacutical Private Limited has 4 board changes on record since 2014: 3 appointments and 1 cessation. The latest: Nagendra Bahadur Singh ceased to be Director on 12 May 2025.
Ceased
Nagendra Bahadur Singh ceased to be Director.
Appointed
Shweta Singh was appointed as Director.
AGM
Nasa Pharamacutical Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Charges
A charge with State Bank Of India amounted to Rs. 10.00 Lakh with Charge ID 100773179 was registered on 26 Jul 2023.
Filing
Nasa Pharamacutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Appointed
Abhay Pratap Singh was appointed as Director.
Appointed
Nagendra Bahadur Singh was appointed as Director.
Incorporation
28 Jan 2014
Nasa Pharamacutical Private Limited was registered on 28 Jan 2014 with Roc Delhi & aged 12 years 8 months as per MCA records.
Frequently asked questions
Nasa Pharamacutical is an active private limited company based in New Delhi, Delhi, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 28 January 2014 (12+ years old) and is registered under CIN U33110DL2014PTC264095.
Nasa Pharamacutical has 3 current directors:
- Nagendra Bahadur Singh - Director
- Abhay Pratap Singh - Director
- Shweta Singh - Director
The latest financial statements of Nasa Pharamacutical on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.
The GSTIN of Nasa Pharamacutical is 05AAECN5888Q1ZK, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Nasa Pharamacutical is U33110DL2014PTC264095. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nasa Pharamacutical was incorporated on 28 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Nasa Pharamacutical by revenue are Mace Pharma Private Limited, Americ N Astos Medicament Private Limited, Aptic Pharmaceuticals Private Limited, Fountil Life Sciences Private Limited, Lyrid Health Care (Bangalore) Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Nagendra Bahadur Singh ceased to be Director on 12 May 2025. Shweta Singh was appointed as Director on 03 May 2025. Abhay Pratap Singh was appointed as Director on 28 Jan 2014. Nasa Pharamacutical has 4 board changes on record in total.
Yes, Nasa Pharamacutical is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-05-0021794).
Nasa Pharamacutical can be reached through the website nasapharmaceutical.in. Its registered office is in New Delhi, Delhi, India.
The registered office of Nasa Pharamacutical is at S – 505 School Block Shakarpur, New Delhi, Delhi, India – 110092.